Results 141 to 150 of about 87,103 (196)
Insights about use of p57 in differentiation between complete and partial hydatidiform mole: a scoping review. [PDF]
Teixeira IS, Botogoski SR, Nisihara R.
europepmc +1 more source
Uncommon causes of acute small intestinal bleeding-invasive mole: A case report and review of literature. [PDF]
Yu WH, Zong Y, Zhou JW, Xu GQ.
europepmc +1 more source
Partial hydatidiform mole coexists with a living fetus: a case report. [PDF]
Karimi M, Alizadeh A.
europepmc +1 more source
An Unclassifiable Malignant Ovarian Germ Cell Tumor With Focal Choriocarcinoma-Like Features: A Case Report With Diagnostic Ambiguity and Adjuvant Treatment Considerations. [PDF]
Takeuchi T +4 more
europepmc +1 more source
Center For The Treatment of Gestational Trophoblastic Neoplasms
D E, Reid +3 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Gestational trophoblastic neoplasms
Gynecologic Oncology, 1974A review of the classification, biological behavior, clinical diagnosis, and treatment of gestational trophoblastic neoplasms is presented. The events which followed the utilization of chemotherapy as a successful means of therapy are included. Especially important has been the recent recognition that high risk patients, i.e., patients with HCG titers ...
R D, Hilgers, J L, Lewis
openaire +2 more sources
Gestational Trophoblastic Neoplasms
Journal of Obstetric, Gynecologic & Neonatal Nursing, 1986Gestational trophoblastic neoplasms have evolved from one of the most rapidly fatal malignancies to potentially one of the most curable, but these diseases have devastating emotional effects on the victims. Etiology, epidemiology, pathophysiology, diagnosis, and medical treatment are reviewed.
S M, Celeste, M D, Smith
openaire +2 more sources
Pregnancies after Chemotherapy of Trophoblastic Neoplasms
Science, 1970We have analyzed 88 pregnancies in 50 women who had previously been treated for gestational trophoblastic neoplasms with chemotherapeutic agents. No increase in fetal wastage, congenital abnormalities or complicated pregnancies was noted, suggesting that these drugs do not damage human oocytes in the doses and time periods used.
Griff T Ross +2 more
exaly +3 more sources

